Hao Hu

Hao Hu

Auto-generated profile, based on publicly available information

Hao Hu

Department of Physics, Arizona State University, Tempe, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
Aleksandra LugininaAleksandra Luginina
Aleksandra Luginina
AGAnastasiia Gusach
Anastasiia Gusach
EMEgor Marin
Egor Marin
AMAlexey Mishin
Alexey Mishin
RBRebecca Brouillette
Rebecca Brouillette
VCVadim Cherezov
Vadim Cherezov
Two distinct antagonist-bound structures of CysLT 1 R reveal unique ligand-binding modes and signaling mechanisms.

12 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ELElizaveta Lyapina
Elizaveta Lyapina
EMEgor Marin
Egor Marin
AGAnastasiia Gusach
Anastasiia Gusach
Philipp OrekhovPhilipp Orekhov
Philipp Orekhov
Gerasimov AndreiGerasimov Andrei
Gerasimov Andrei
VCVadim Cherezov
Vadim Cherezov
The bioactive lysophospholipid sphingosine-1-phosphate (S1P) acts via five different subtypes of S1P receptors (S1PRs) - S1P1-5. S1P5 is predominantly expressed in nervous and immune systems, regulating the egress of natural killer cells from lymph nodes and playing a role in immune and neurodegenerative disorders, as well as carcinogenesis. Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor subtype selectivity, which leads to side effects. In this article, we describe a 2.2 Å resolution room temperature crystal structure of the human S1P5 receptor in complex with a selective inverse agonist determined by serial femtosecond crystallography (SFX) at the Pohang Accelerator Laboratory X-Ray Free Electron Laser (PAL-XFEL) and analyze its structure-activity relationship data. The structure demonstrates a unique ligand-binding mode, involving an allosteric sub-pocket, which clarifies the receptor subtype selectivity and provides a template for structure-based drug design. Together with previously published S1PR structures in complex with antagonists and agonists, our structure with S1P5-inverse agonist sheds light on the activation mechanism and reveals structural determinants of the inverse agonism in the S1PR family.

12 June 2025 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
Tek Narsingh MallaTek Narsingh Malla
Tek Narsingh Malla
LALuis Aldama
Luis Aldama
VLViridiana Leon
Viridiana Leon
DFDenisse Feliz
Denisse Feliz
HHHao Hu
Hao Hu
MSMarius Schmidt
Marius Schmidt
Myxobacteria are non-photosynthetic, soil-dwelling bacteria distinguished by a multicellular stage in their life cycle known as fruiting bodies that are stimulated by light. Myxobacterial phytochromes are candidates for the perception of red-light. The mechanism how light is perceived and converted to a physiological response is unknown. Here, time-resolved serial femtosecond crystallographic (TR-SFX) experiments were conducted on microcrystals of the photosensory core module of the Stigmatella aurantiaca bacteriophytochrome 2 (SaBphP2). Initial events of the Z to E isomerization reaction of the covalently bound, open-chain tetrapyrrole biliverdin (BV) chromophore were determined. At 3 ps after light activation, the BV ring-D assumes a configuration needed for the isomerization. At 100 ps, a mixture of BV in the Z or E configuration is observed in subunit A, while in the other subunit the chromophore remains in the Z configuration. In conjunction with prior results, these structures reveal the molecular mechanism of phytochrome activation in the photomorphogenesis of the myxobacteria and provide the molecular foundation for physiological responses to red light in other bacteria.

24 May 2025 in Protein Science
Verified
Journal Article
Open access
MSManashi Sonowal
Manashi Sonowal
GKGihan Ketawala
Gihan Ketawala
NNNirupa Nagaratnam
Nirupa Nagaratnam
DLDhenugen Logeswaran
Dhenugen Logeswaran
Shibom BasuShibom Basu
Shibom Basu
PFPetra Fromme
Petra Fromme
SARS‐CoV‐2, the virus responsible for the COVID‐19 pandemic, has undergone continuous evolution, leading to the emergence of variants with altered transmissibility and immune evasion. For the non‐structural proteins (Nsps) of SARS‐CoV‐2, there are limited structural analyses of their naturally occurring mutations. Here, we identified four non‐synonymous single‐nucleotide polymorphisms (nsSNPs) in the Epsilon lineage of SARS‐CoV‐2 within Nsp15, an endoribonuclease critical for immune evasion. Of these Epsilon nsSNPs, E266Q is in the catalytic domain. This study investigates the effects of this on enzymatic activity, structural stability, and oligomeric assembly by serial crystallography. By solving the structure of the Nsp15 hexamer at room temperature of both Nsp15‐E266Q and WT in the P21 space group to 3 Å, we observed asymmetric motions within its trimer subunits, a feature not visible in previously reported higher‐symmetry space groups. These asymmetric motions resemble substrate‐induced conformational changes reported in RNA‐bound Nsp15 structures, suggesting functional relevance. Biochemical analyses further reveal that Nsp15‐E266Q exhibited significantly higher enzymatic activity and thermal stability compared to the wild‐type protein. These findings highlight how mutations in Nsp15 contribute to viral replication and immune evasion, offering insights into the molecular mechanisms underlying SARS‐CoV‐2 variant evolution and potential therapeutic strategies.

20 July 2019 in Acta Crystallographica Section A Foundations and Advances
Verified
Journal Article
Open access
HLHaiguang Liu
Haiguang Liu
JYJi-Hye Yun
Ji-Hye Yun
XLXuanxuan Li
Xuanxuan Li
JPJae-Hyun Park
Jae-Hyun Park
ZJZeyu Jin
Zeyu Jin
Weontae LeeWeontae Lee
Weontae Lee

26 February 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
ELElizaveta Lyapina
Elizaveta Lyapina
EMEgor Marin
Egor Marin
AGAnastasiia Gusach
Anastasiia Gusach
Philipp OrekhovPhilipp Orekhov
Philipp Orekhov
Gerasimov AndreiGerasimov Andrei
Gerasimov Andrei
VCVadim Cherezov
Vadim Cherezov
The bioactive lysophospholipid sphingosine-1-phosphate (S1P) acts via five different subtypes of S1P receptors (S1PR) - S1P 1-5 . S1P 5 is predominantly expressed in nervous and immune systems, regulating the egress of natural killer cells from lymph nodes and playing a role in immune and neurodegenerative disorders, as well as carcinogenesis. Several S1PR therapeutic drugs have been developed to treat these diseases; however, they lack receptor subtype selectivity, which leads to side effects. In this article, we describe a 2.2 Å resolution room temperature crystal structure of the human S1P 5 receptor in complex with a selective inverse agonist determined by serial femtosecond crystallography (SFX) at the Pohang Accelerator Laboratory X-Ray Free Electron Laser (PAL-XFEL) and analyze its structure-activity relationship data. The structure demonstrates a unique ligand-binding mode, involving an allosteric subpocket, which clarifies the receptor subtype selectivity and provides a template for structure-based drug design. Together with previously published S1PR structures in complex with antagonists and agonists, the new S1P 5 -inverse agonist structure sheds light on the activation mechanism and reveals structural determinants of the inverse agonism in the S1PR-family.